期刊文献+

2010~2012年我院抗菌药使用强度调查 被引量:7

Survey of Antibacterial Use Density in our Hospital during 2010-2012
原文传递
导出
摘要 目的:分析我院住院患者抗菌药的应用情况及趋势,为合理使用抗菌药提供依据。方法:回顾性收集我院2010—2012年出院患者抗茵药的使用记录,以限定El剂量(DDD)为单位,计算抗茵药使用强度(AUD)并进行分析。结果:我院抗茵药使用强度3年来呈下降趋势,由2010年的68.63DDD/100人天下降到2012年的42.6lDDD/100人天,尤以手术科室下降明显。头孢菌素类复方制剂、第三代头孢菌素始终位居前3位,喹诺酮类抗茵药使用强度下降明显。结论:我院存在用药过度、用药集中等问题。应严格限制头孢菌素类复方制剂、第三代头孢菌素临床应用,提高合理用药水平。 Objective: To provide an evidence for rational clinical use of antibacterials through analysis of the ap- plication and trend of antibacterials in the inpatients of our hospital. Methods : By retrospective study, the data of drug used during 2010-2012 were collected and analyzed. With the defined daily dose(DDD) as the .unit,antibacterial use density (AUD) was calculated and its analysis Was made . Results:The AUD in our hospital markedly decreased from 68.63 DDD / 100 persons/d in 2010 to 42.61 DDD/100 persons/d in 2012 in the past 3 year, especially in the surgical departments. Cephalosporins compound preparation and third generation cephalosporins always ranked in the first three places. But quin- olones significantly decreased. Conclusion: Antimicrobial drug use in the clinic in our hospital might have such problems as overmedication, dense medication. Cephalosporins compound preparation and third generation eephalosporins should be strictly restricted in clinical appligation in order to improve the rational use of drugs.
出处 《药物流行病学杂志》 CAS 2013年第11期609-612,共4页 Chinese Journal of Pharmacoepidemiology
关键词 抗菌药 限定日剂量 使用强度 药物利用 Antibacterials Defined daily dose Antibiotics use density Drug utilization
  • 相关文献

参考文献8

二级参考文献43

共引文献96

同被引文献32

  • 1卫生部办公厅关于抗菌药物临床应用管理有关问题的通知(卫办医政发〔2009〕38号)[J].中华人民共和国卫生部公报,2009(6):43-45. 被引量:44
  • 2Hsueh PR, Chen WH, Luh KT. Re|ationships between antimierobial use and antimicrobiaI resistance in Gram - negative bacteria causing nos- ocomial infections from 1991--2003 at a university hospital in Taiwan [J]. Int J Antimicrob Agents, 2005, 26 (6) : 463 -472.
  • 3卫生部.抗菌药物临床应用管理办法(卫生部令第84号)[S].2012.
  • 4国家食品药品监督管理局执业药师资格认证中心药学专业知识(一)[M].北京:中国中医药出版社,2008:54-85.
  • 5Hsueh P R, Chen W H, Luh K T. Relationships between antimi- crobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan[J]. Int J Antimicrob Agent s,2005,26(6):463-472.
  • 6MacDougall C, Powell J P, Johnson C K, et al. Hospital and com- munity fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals[J]. Clin Infect Dis, 2005,41(4):435-440.
  • 7Goldmann D A, Huskins W C. Control of nosocomial antimicro- bial-resistant bacteria: a strategic priority for hospitals worldwide[J]. Clin Infect Dis,1997,24(Suppll):S139-145.
  • 8White R L, Friedrich L V, Mihm L B, et al. Assessment of the re- lationship between antimicrobial usage and susceptibility: differen- ces between the hospital and specific patient-care areas[J]. Clin Infect Dis ,2000,31(1):16-23.
  • 9Ray G T, Baxter R, DeLorenze G N. Hospital-level rates of fluo- roquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptiblePseudomonas aeruginosa[J]. Clin Infect Dis,2005,41 (4):441-449.
  • 10崔兰贵,张磊,朱铁梁,吴志恒,赵榕慧,朱洁.抗菌药物滥用与医院感染管理[J].中华医院感染学杂志,2009,19(15):2010-2011. 被引量:74

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部